Chenlu Ke
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Chenlu Ke has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Dipankar Bandyopadhyay
Virginia Commonwealth University
4 shared publications Atika Farzana Urmi
Department of Biostatistics Virginia Commonwealth University Richmond Virginia USA
1 shared publication- Atika Farzana Urmi
Department of Biostatistics, Virginia Commonwealth University
1 shared publication - Craig S. Miller
Department of Oral Health Practice, University of Kentucky, College of Dentistry
1 shared publication - Derek S. Young
Dr. Bing Zhang Department of Statistics, University of Kentucky, Lexington, USA
1 shared publication - Devanand Sarkar
Department of Cellular, Molecular and Genetic Medicine, Massey Comprehensive Cancer Center, Virginia Commonwealth University, Richmond, VA 23298, USA
1 shared publication
Latest Publications
- Open Access
- 15 July 2025
- Published by Wiley in Statistics in Medicine
- Vol. 44 (15-17) , e70167
α$ \alpha $‐KIDS: A Novel Feature Evaluation in the Ultrahigh‐Dimensional Right‐Censored Setting, With Application to Head and Neck CancerRecent advances in sequencing technologies have allowed the collection of massive genome‐wide information that substantially enhances the diagnosis and prognosis of head and neck cancer. Identifying predictive markers for survival time is crucial for devising prognostic systems and learning the underlying molecular drivers of the cancer course. In this paper, we introduce ‐KIDS, a model‐free feature screening procedure with false discovery rate (FDR) control for ultrahigh‐dimensional right‐censored data, which is robust against unknown censoring mechanisms. Specifically, our two‐stage procedure initially selects a set of important features with a dual screening mechanism using nonparametric reproducing‐kernel‐based ANOVA statistics, followed by identifying a refined set of features under FDR control through a unified knockoff procedure. The finite sample properties of our method and its novelty (in light of existing alternatives) are evaluated via simulation studies. Furthermore, we illustrate our methodology via application to a motivating right‐censored head and neck (HN) cancer survival data derived from The Cancer Genome Atlas, with further validation on a similar HN cancer data from the Gene Expression Omnibus database. The methodology can be implemented using the R package aKIDS , which is available on GitHub .
- 15 July 2025
- Published by Wiley in Statistics in Medicine
- Vol. 44 (15-17) , e70167
Open Accessα$ \alpha $‐KIDS: A Novel Feature Evaluation in the Ultrahigh‐Dimensional Right‐Censored Setting, With Application to Head and Neck CancerRecent advances in sequencing technologies have allowed the collection of massive genome‐wide information that substantially enhances the diagnosis and prognosis of head and neck cancer. Identifying predictive markers for survival time is crucial for devising prognostic systems and learning the underlying molecular drivers of the cancer course. In this paper, we introduce ‐KIDS, a model‐free feature screening procedure with false discovery rate (FDR) control for ultrahigh‐dimensional right‐censored data, which is robust against unknown censoring mechanisms. Specifically, our two‐stage procedure initially selects a set of important features with a dual screening mechanism using nonparametric reproducing‐kernel‐based ANOVA statistics, followed by identifying a refined set of features under FDR control through a unified knockoff procedure. The finite sample properties of our method and its novelty (in light of existing alternatives) are evaluated via simulation studies. Furthermore, we illustrate our methodology via application to a motivating right‐censored head and neck (HN) cancer survival data derived from The Cancer Genome Atlas, with further validation on a similar HN cancer data from the Gene Expression Omnibus database. The methodology can be implemented using the R package aKIDS , which is available on GitHub .
- Open Access
α -KIDS: A novel feature evaluation in the ultrahigh-dimensional right-censored setting, with application to Head and Neck Cancer
A bstract: Recent advances in sequencing technologies have allowed collection of massive genome-wide information that substantially enhances the diagnosis and prognosis of head and neck cancer. Identifying predictive markers for survival time is crucial for devising prognostic systems, and learning the underlying molecular driver of the cancer course. In this paper, we introduce α -KIDS, a model-free feature screening procedure with false discovery rate (FDR) control for ultrahigh dimensional right-censored data, which is robust against unknown censoring mechanisms. Specifically, our two-stage procedure initially selects a set of important features with a dual screening mechanism using nonparametric reproducing-kernel-based ANOVA statistics, followed by identifying a refined set (of features) under directional FDR control through a unified knockoff procedure. The finite sample properties of our method, and its novelty (in light of existing alternatives) are evaluated via simulation studies. Furthermore, we illustrate our methodology via application to a motivating right-censored head and neck (HN) cancer survival data derived from The Cancer Genome Atlas, with further validation on a similar HN cancer data from the Gene Expression Omnibus database. The methodology can be implemented via the R package DSFDRC, available in GitHub.
Open Accessα -KIDS: A novel feature evaluation in the ultrahigh-dimensional right-censored setting, with application to Head and Neck Cancer
A bstract: Recent advances in sequencing technologies have allowed collection of massive genome-wide information that substantially enhances the diagnosis and prognosis of head and neck cancer. Identifying predictive markers for survival time is crucial for devising prognostic systems, and learning the underlying molecular driver of the cancer course. In this paper, we introduce α -KIDS, a model-free feature screening procedure with false discovery rate (FDR) control for ultrahigh dimensional right-censored data, which is robust against unknown censoring mechanisms. Specifically, our two-stage procedure initially selects a set of important features with a dual screening mechanism using nonparametric reproducing-kernel-based ANOVA statistics, followed by identifying a refined set (of features) under directional FDR control through a unified knockoff procedure. The finite sample properties of our method, and its novelty (in light of existing alternatives) are evaluated via simulation studies. Furthermore, we illustrate our methodology via application to a motivating right-censored head and neck (HN) cancer survival data derived from The Cancer Genome Atlas, with further validation on a similar HN cancer data from the Gene Expression Omnibus database. The methodology can be implemented via the R package DSFDRC, available in GitHub.
- 26 May 2023
- Published by Elsevier in Computational Statistics & Data Analysis
- Vol. 187
Partial sufficient variable screening with categorical controls
- 26 May 2023
- Published by Elsevier in Computational Statistics & Data Analysis
- Vol. 187
Partial sufficient variable screening with categorical controls
- Open Access
Gene Screening for Prognosis of Non-Muscle-Invasive Bladder Carcinoma under Competing Risks Endpoints
Background: Discovering clinically useful molecular markers for predicting the survival of patients diagnosed with non–muscle-invasive bladder cancer can provide insights into cancer dynamics and improve treatment outcomes. However, the presence of competing risks (CR) endpoints complicates the estimation and inferential framework. There is also a lack of statistical analysis tools and software for coping with the high-throughput nature of these data, in terms of marker screening and selection. Aims: To propose a gene screening procedure for proportional subdistribution hazards regression under a CR framework, and illustrate its application in using molecular profiling to predict survival for non-muscle invasive bladder carcinoma. Methods: Tumors from 300 patients diagnosed with bladder cancer were analyzed for genomic abnormalities while controlling for clinically important covariates. Genes with expression patterns that were associated with survival were identified through a screening procedure based on proportional subdistribution hazards regression. A molecular predictor of risk was constructed and examined for prediction accuracy. Results: A six-gene signature was found to be a significant predictor associated with survival of non–muscle-invasive bladder cancer, subject to competing risks after adjusting for age, gender, reevaluated WHO grade, stage and BCG/MMC treatment (p-value < 0.001). Conclusion: The proposed gene screening procedure can be used to discover molecular determinants of survival for non–muscle-invasive bladder cancer and in general facilitate high-throughput competing risks data analysis with easy implementation.
Open AccessGene Screening for Prognosis of Non-Muscle-Invasive Bladder Carcinoma under Competing Risks Endpoints
Background: Discovering clinically useful molecular markers for predicting the survival of patients diagnosed with non–muscle-invasive bladder cancer can provide insights into cancer dynamics and improve treatment outcomes. However, the presence of competing risks (CR) endpoints complicates the estimation and inferential framework. There is also a lack of statistical analysis tools and software for coping with the high-throughput nature of these data, in terms of marker screening and selection. Aims: To propose a gene screening procedure for proportional subdistribution hazards regression under a CR framework, and illustrate its application in using molecular profiling to predict survival for non-muscle invasive bladder carcinoma. Methods: Tumors from 300 patients diagnosed with bladder cancer were analyzed for genomic abnormalities while controlling for clinically important covariates. Genes with expression patterns that were associated with survival were identified through a screening procedure based on proportional subdistribution hazards regression. A molecular predictor of risk was constructed and examined for prediction accuracy. Results: A six-gene signature was found to be a significant predictor associated with survival of non–muscle-invasive bladder cancer, subject to competing risks after adjusting for age, gender, reevaluated WHO grade, stage and BCG/MMC treatment (p-value < 0.001). Conclusion: The proposed gene screening procedure can be used to discover molecular determinants of survival for non–muscle-invasive bladder cancer and in general facilitate high-throughput competing risks data analysis with easy implementation.
- Open Access
Gene Screening in High-Throughput Right-Censored Lung Cancer Data
Background: Advances in sequencing technologies have allowed collection of massive genome-wide information that substantially advances lung cancer diagnosis and prognosis. Identifying influential markers for clinical endpoints of interest has been an indispensable and critical component of the statistical analysis pipeline. However, classical variable selection methods are not feasible or reliable for high-throughput genetic data. Our objective is to propose a model-free gene screening procedure for high-throughput right-censored data, and to develop a predictive gene signature for lung squamous cell carcinoma (LUSC) with the proposed procedure. Methods: A gene screening procedure was developed based on a recently proposed independence measure. The Cancer Genome Atlas (TCGA) data on LUSC was then studied. The screening procedure was conducted to narrow down the set of influential genes to 378 candidates. A penalized Cox model was then fitted to the reduced set, which further identified a 6-gene signature for LUSC prognosis. The 6-gene signature was validated on datasets from the Gene Expression Omnibus. Results: Both model-fitting and validation results reveal that our method selected influential genes that lead to biologically sensible findings as well as better predictive performance, compared to existing alternatives. According to our multivariable Cox regression analysis, the 6-gene signature was indeed a significant prognostic factor (p-value < 0.001) while controlling for clinical covariates. Conclusions: Gene screening as a fast dimension reduction technique plays an important role in analyzing high-throughput data. The main contribution of this paper is to introduce a fundamental yet pragmatic model-free gene screening approach that aids statistical analysis of right-censored cancer data, and provide a lateral comparison with other available methods in the context of LUSC.
Open AccessGene Screening in High-Throughput Right-Censored Lung Cancer Data
Background: Advances in sequencing technologies have allowed collection of massive genome-wide information that substantially advances lung cancer diagnosis and prognosis. Identifying influential markers for clinical endpoints of interest has been an indispensable and critical component of the statistical analysis pipeline. However, classical variable selection methods are not feasible or reliable for high-throughput genetic data. Our objective is to propose a model-free gene screening procedure for high-throughput right-censored data, and to develop a predictive gene signature for lung squamous cell carcinoma (LUSC) with the proposed procedure. Methods: A gene screening procedure was developed based on a recently proposed independence measure. The Cancer Genome Atlas (TCGA) data on LUSC was then studied. The screening procedure was conducted to narrow down the set of influential genes to 378 candidates. A penalized Cox model was then fitted to the reduced set, which further identified a 6-gene signature for LUSC prognosis. The 6-gene signature was validated on datasets from the Gene Expression Omnibus. Results: Both model-fitting and validation results reveal that our method selected influential genes that lead to biologically sensible findings as well as better predictive performance, compared to existing alternatives. According to our multivariable Cox regression analysis, the 6-gene signature was indeed a significant prognostic factor (p-value < 0.001) while controlling for clinical covariates. Conclusions: Gene screening as a fast dimension reduction technique plays an important role in analyzing high-throughput data. The main contribution of this paper is to introduce a fundamental yet pragmatic model-free gene screening approach that aids statistical analysis of right-censored cancer data, and provide a lateral comparison with other available methods in the context of LUSC.
- 19 May 2022
- Published by Elsevier in Computational Statistics & Data Analysis
- Vol. 174, 107530
Independence index sufficient variable screening for categorical responses
- 19 May 2022
- Published by Elsevier in Computational Statistics & Data Analysis
- Vol. 174, 107530
Independence index sufficient variable screening for categorical responses
- 1 October 2020
- Published by Elsevier in Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
- Vol. 130 (4) , 402-410
Prescribing patterns of opioid analgesics in a dental setting: 2013–2018
- 1 October 2020
- Published by Elsevier in Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
- Vol. 130 (4) , 402-410
Prescribing patterns of opioid analgesics in a dental setting: 2013–2018
- Open Access
- 6 June 2018
- Published by Taylor & Francis in Journal of Computational and Graphical Statistics
- Vol. 27 (3) , 564-575
The Mixturegram: A Visualization Tool for Assessing the Number of Components in Finite Mixture Models
Certain practical and theoretical challenges surround the estimation of finite mixture models. One such challenge is how to determine the number of components when this is not assumed a priori. Available methods in the literature are primarily numerical and lack any substantial visualization component. Traditional numerical methods include the calculation of information criteria and bootstrapping approaches; however, such methods have known technical issues regarding the necessary regularity conditions for testing the number of components. The ability to visualize an appropriate number of components for a finite mixture model could serve to supplement the results from traditional methods or provide visual evidence when results from such methods are inconclusive. Our research fills this gap through development of a visualization tool, which we call a mixturegram. This tool is easy to implement and provides a quick way for researchers to assess the number of components for their hypothesized mixture model. Mixtures of univariate or multivariate data can be assessed. We validate our visualization assessments by comparing with results from information criteria and an ad hoc selection criterion based on calculations used for the mixturegram. We also construct the mixturegram for two datasets.
- 6 June 2018
- Published by Taylor & Francis in Journal of Computational and Graphical Statistics
- Vol. 27 (3) , 564-575
Open AccessThe Mixturegram: A Visualization Tool for Assessing the Number of Components in Finite Mixture Models
Certain practical and theoretical challenges surround the estimation of finite mixture models. One such challenge is how to determine the number of components when this is not assumed a priori. Available methods in the literature are primarily numerical and lack any substantial visualization component. Traditional numerical methods include the calculation of information criteria and bootstrapping approaches; however, such methods have known technical issues regarding the necessary regularity conditions for testing the number of components. The ability to visualize an appropriate number of components for a finite mixture model could serve to supplement the results from traditional methods or provide visual evidence when results from such methods are inconclusive. Our research fills this gap through development of a visualization tool, which we call a mixturegram. This tool is easy to implement and provides a quick way for researchers to assess the number of components for their hypothesized mixture model. Mixtures of univariate or multivariate data can be assessed. We validate our visualization assessments by comparing with results from information criteria and an ad hoc selection criterion based on calculations used for the mixturegram. We also construct the mixturegram for two datasets.